Equity Overview
Price & Market Data
Price: $0.345
Daily Change: -$0.0671 / 19.45%
Range: $0.314 - $0.412
Market Cap: $8,101,989
Volume: 2,331,328
Performance Metrics
1 Week: -1.10%
1 Month: -84.50%
3 Months: -93.01%
6 Months: -94.61%
1 Year: -98.75%
YTD: -94.33%
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.